Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

164
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
164
Hazard Ratio01:12

Hazard Ratio

549
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
549
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

382
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
382
Study Design in Statistics01:15

Study Design in Statistics

9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K
Odds Ratio01:09

Odds Ratio

1.5K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
1.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Nutritional screening within the GLIM procedure-Part 1: Development of a conceptual definition of risk of malnutrition using a modified Delphi procedure.

JPEN. Journal of parenteral and enteral nutrition·2026
Same author

Nutritional screening within the GLIM procedure-Part 2: Operationalization of the concept risk of malnutrition using a modified Delphi procedure.

JPEN. Journal of parenteral and enteral nutrition·2026
Same author

Nutritional screening within the GLIM procedure-Part 1: Development of a conceptual definition of risk of malnutrition using a modified Delphi procedure.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Nutritional screening within the GLIM procedure-Part 2: Operationalization of the concept risk of malnutrition using a modified Delphi procedure.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

High-Dose Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury: The VICTORY Randomized Clinical Trial.

JAMA·2026
Same author

Which critically ill patients are more susceptible to the adverse effects associated with feeding intolerance? A secondary analysis of a cluster-randomized controlled trial.

Frontiers in nutrition·2026

相关实验视频

Updated: Jan 9, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

对于二分结果的试验顺序分析 - 一个系统审查协议的实用指南.

Sophie Juul1,2,3, Christian Gunge Riberholt4,5,6, Markus Harboe Olsen4,6

  • 1Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. sophie.juul@ctu.dk.

BMC medical research methodology
|December 5, 2025
PubMed
概括

试验序列分析 (TSA) 有常见的规划和报告错误. 本指南详细介绍了系统审查中准确的TSA的五个关键参数,以提高有效性和可重复性.

关键词:
临床试验方法论 临床试验方法论不准确性 不准确性进行元分析分析.随机错误 随机错误是指随机错误的发生.系统性审查 系统性审查试验的顺序分析.

更多相关视频

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

456

相关实验视频

Last Updated: Jan 9, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

456

科学领域:

  • 统计方法学的统计方法.
  • 基于证据的医学是基于证据的医学.
  • 临床试验分析临床试验分析

背景情况:

  • 试验序列分析 (TSA) 对于控制随机临床试验元分析中的随机错误至关重要.
  • 试验顺序分析 (METSA) 项目的重大错误和错误在大多数TSA中发现了重要的预先规划和报告缺陷.
  • 这篇文章提供了一份系统审查协议的实用指南,用于规划TSA的二元化结果.

研究的目的:

  • 为系统审查协议的作者提供关于计划试验序列分析 (TSA) 的实用指南.
  • 解决TSA预先规划和报告中发现的常见错误和错误.
  • 为了提高TSA的解释性,可重现性和有效性,需要进行系统性审查.

主要方法:

  • 该指南基于TSA手册和之前的建议.
  • 它结合了METSA项目的发现,该项目评估了TSA在医疗领域的使用情况.
  • 专注于为二分结果规划TSA的实际考虑.

主要成果:

  • 在承担TSA之前,必须在协议中定义五个基本参数.
  • 这些参数包括对照组事件比例,相对风险变化,I型错误 (α),II型错误 (β) 和元分析多样性.
  • 清晰地定义这些参数可以提高TSA的解释性,可复制性和有效性.

结论:

  • 本指南旨在改善针对二分结果的TSA的预注册和报告.
  • 它将帮助作者创建更强大的系统审查协议.
  • 最终,它旨在提高随机临床试验中的元分析的质量.